A Study for Participants With Metastatic Renal Cell Carcinoma

NCT00709995 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Enzastaurin
DRUG: Sunitinib
DRUG: Placebo

Sponsor

Eli Lilly and Company